APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intravenous Immunoglobulin(IVIg) Therapy

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Intravenous Immunoglobulin(IVIg) Therapy Market Analysis and Forecast 2026-2032

30 December 2025204 pages

Choose your research edition.

Industry ResearchIntravenous Immunoglobulin(IVIg) Therapy Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous Immunoglobulin(IVIg) Therapy Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Intravenous Immunoglobulin(IVIg) Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous Immunoglobulin(IVIg) Therapy Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous Immunoglobulin(IVIg) Therapy Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Intravenous Immunoglobulin(IVIg) Therapy market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Intravenous Immunoglobulin(IVIg) Therapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Intravenous Immunoglobulin(IVIg) Therapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Intravenous Immunoglobulin(IVIg) Therapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Intravenous Immunoglobulin(IVIg) Therapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Intravenous Immunoglobulin(IVIg) Therapy include TEIJIN LIMITED, Baxter, Biotest, Boya-Bio, CNBG, CSL Plasma, Grifols, Kamada and Kedrion, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Intravenous Immunoglobulin(IVIg) Therapy, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Intravenous Immunoglobulin(IVIg) Therapy, also provides the sales of main regions and countries. Of the upcoming market potential for Intravenous Immunoglobulin(IVIg) Therapy, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Intravenous Immunoglobulin(IVIg) Therapy sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Intravenous Immunoglobulin(IVIg) Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Intravenous Immunoglobulin(IVIg) Therapy sales, projected growth trends, production technology, application and end-user industry.

Intravenous Immunoglobulin(IVIg) Therapy Segment by Company

TEIJIN LIMITED

Baxter

Biotest

Boya-Bio

CNBG

CSL Plasma

Grifols

Kamada

Kedrion

LFB Group

Nanyue Biopharming

Octapharma

Sinopharm

Beijing Tiantan Biological Products

Guangdong Shuagnlin Bio-pharmacy

Hualan Bio

Shanghai RAAS

Weiguang Biological

Taibang Biologic Group

Takeda

Intravenous Immunoglobulin(IVIg) Therapy Segment by Type

5g/100ml

2.5g/50ml

1g/20ml

10g/200ml

1.25g/25ml

Others

Intravenous Immunoglobulin(IVIg) Therapy Segment by Application

Autoimmune Disease

Immunodeficiency

Acute Infection

Others

Intravenous Immunoglobulin(IVIg) Therapy Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Immunoglobulin(IVIg) Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous Immunoglobulin(IVIg) Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Immunoglobulin(IVIg) Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Intravenous Immunoglobulin(IVIg) Therapy in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Intravenous Immunoglobulin(IVIg) Therapy manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intravenous Immunoglobulin(IVIg) Therapy sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Intravenous Immunoglobulin(IVIg) Therapy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 5g/100ml Major Manufacturers Table 3. 2.5g/50ml Major Manufacturers Table 4. 1g/20ml Major Manufacturers Table 5. 10g/200ml Major Manufacturers Table 6. 1.25g/25ml Major Manufacturers Table 7. Others Major Manufacturers Table 8. Global Intravenous Immunoglobulin(IVIg) Therapy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Autoimmune Disease Major Manufacturers Table 10. Immunodeficiency Major Manufacturers Table 11. Acute Infection Major Manufacturers Table 12. Others Major Manufacturers Table 13. Intravenous Immunoglobulin(IVIg) Therapy Industry Trends Table 14. Intravenous Immunoglobulin(IVIg) Therapy Industry Drivers Table 15. Intravenous Immunoglobulin(IVIg) Therapy Industry Opportunities and Challenges Table 16. Intravenous Immunoglobulin(IVIg) Therapy Industry Restraints Table 17. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Region (2021-2026) Table 21. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Region (2027-2032) Table 22. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 23. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Region (2021-2026) & (K Units) Table 24. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Region (2027-2032) & (K Units) Table 25. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Region (2021-2026) Table 26. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Region (2027-2032) Table 27. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Manufacturers (2021-2026) Table 31. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 32. Global Intravenous Immunoglobulin(IVIg) Therapy Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Intravenous Immunoglobulin(IVIg) Therapy Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Intravenous Immunoglobulin(IVIg) Therapy Manufacturers, Product Type & Application Table 35. Global Intravenous Immunoglobulin(IVIg) Therapy Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Intravenous Immunoglobulin(IVIg) Therapy by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Type (2021-2026) Table 42. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Type (2027-2032) Table 43. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 44. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026) & (K Units) Table 45. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2027-2032) & (K Units) Table 46. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2021-2026) Table 47. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2027-2032) Table 48. Global Intravenous Immunoglobulin(IVIg) Therapy Price by Type (2021-2026) & (US$/Unit) Table 49. Global Intravenous Immunoglobulin(IVIg) Therapy Price by Type (2027-2032) & (US$/Unit) Table 50. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Application (2021-2026) Table 54. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Application (2027-2032) Table 55. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 56. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026) & (K Units) Table 57. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2027-2032) & (K Units) Table 58. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2021-2026) Table 59. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2027-2032) Table 60. Global Intravenous Immunoglobulin(IVIg) Therapy Price by Application (2021-2026) & (US$/Unit) Table 61. Global Intravenous Immunoglobulin(IVIg) Therapy Price by Application (2027-2032) & (US$/Unit) Table 62. TEIJIN LIMITED Company Information Table 63. TEIJIN LIMITED Business Overview Table 64. TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 66. TEIJIN LIMITED Recent Development Table 67. Baxter Company Information Table 68. Baxter Business Overview Table 69. Baxter Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Baxter Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 71. Baxter Recent Development Table 72. Biotest Company Information Table 73. Biotest Business Overview Table 74. Biotest Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Biotest Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 76. Biotest Recent Development Table 77. Boya-Bio Company Information Table 78. Boya-Bio Business Overview Table 79. Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 81. Boya-Bio Recent Development Table 82. CNBG Company Information Table 83. CNBG Business Overview Table 84. CNBG Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. CNBG Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 86. CNBG Recent Development Table 87. CSL Plasma Company Information Table 88. CSL Plasma Business Overview Table 89. CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 91. CSL Plasma Recent Development Table 92. Grifols Company Information Table 93. Grifols Business Overview Table 94. Grifols Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Grifols Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 96. Grifols Recent Development Table 97. Kamada Company Information Table 98. Kamada Business Overview Table 99. Kamada Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Kamada Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 101. Kamada Recent Development Table 102. Kedrion Company Information Table 103. Kedrion Business Overview Table 104. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 106. Kedrion Recent Development Table 107. LFB Group Company Information Table 108. LFB Group Business Overview Table 109. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 111. LFB Group Recent Development Table 112. Nanyue Biopharming Company Information Table 113. Nanyue Biopharming Business Overview Table 114. Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 116. Nanyue Biopharming Recent Development Table 117. Octapharma Company Information Table 118. Octapharma Business Overview Table 119. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 121. Octapharma Recent Development Table 122. Sinopharm Company Information Table 123. Sinopharm Business Overview Table 124. Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 126. Sinopharm Recent Development Table 127. Beijing Tiantan Biological Products Company Information Table 128. Beijing Tiantan Biological Products Business Overview Table 129. Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 131. Beijing Tiantan Biological Products Recent Development Table 132. Guangdong Shuagnlin Bio-pharmacy Company Information Table 133. Guangdong Shuagnlin Bio-pharmacy Business Overview Table 134. Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 136. Guangdong Shuagnlin Bio-pharmacy Recent Development Table 137. Hualan Bio Company Information Table 138. Hualan Bio Business Overview Table 139. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 141. Hualan Bio Recent Development Table 142. Shanghai RAAS Company Information Table 143. Shanghai RAAS Business Overview Table 144. Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 146. Shanghai RAAS Recent Development Table 147. Weiguang Biological Company Information Table 148. Weiguang Biological Business Overview Table 149. Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 151. Weiguang Biological Recent Development Table 152. Taibang Biologic Group Company Information Table 153. Taibang Biologic Group Business Overview Table 154. Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 156. Taibang Biologic Group Recent Development Table 157. Takeda Company Information Table 158. Takeda Business Overview Table 159. Takeda Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Takeda Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 161. Takeda Recent Development Table 162. North America Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type (2021-2026) & (US$ Million) Table 163. North America Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type (2027-2032) & (US$ Million) Table 164. North America Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026) & (K Units) Table 165. North America Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2027-2032) & (K Units) Table 166. North America Intravenous Immunoglobulin(IVIg) Therapy Sales Price by Type (2021-2026) & (US$/Unit) Table 167. North America Intravenous Immunoglobulin(IVIg) Therapy Sales Price by Type (2027-2032) & (US$/Unit) Table 168. North America Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application (2021-2026) & (US$ Million) Table 169. North America Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application (2027-2032) & (US$ Million) Table 170. North America Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026) & (K Units) Table 171. North America Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2027-2032) & (K Units) Table 172. North America Intravenous Immunoglobulin(IVIg) Therapy Sales Price by Application (2021-2026) & (US$/Unit) Table 173. North America Intravenous Immunoglobulin(IVIg) Therapy Sales Price by Application (2027-2032) & (US$/Unit) Table 174. North America Intravenous Immunoglobulin(IVIg) Therapy Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. North America Intravenous Immunoglobulin(IVIg) Therapy Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 176. North America Intravenous Immunoglobulin(IVIg) Therapy Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 177. North America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 178. North America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021-2026) & (K Units) Table 179. North America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2027-2032) & (K Units) Table 180. North America Intravenous Immunoglobulin(IVIg) Therapy Sales Price by Country (2021-2026) & (US$/Unit) Table 181. North America Intravenous Immunoglobulin(IVIg) Therapy Sales Price by Country (2027-2032) & (US$/Unit) Table 182. United States Intravenous Immunoglobulin(IVIg) Therapy Revenue (2021-2032) & (US$ Million) Table 183. Canada Intravenous Immunoglobulin(IVIg) Therapy Revenue (2021-2032) & (US$ Million) Table 184. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type (2021-2026) & (US$ Million) Table 185. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type (2027-2032) & (US$ Million) Table 186. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026) & (K Units) Table 187. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2027-2032) & (K Units) Table 188. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Price by Type (2021-2026) & (US$/Unit) Table 189. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Price by Type (2027-2032) & (US$/Unit) Table 190. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application (2021-2026) & (US$ Million) Table 191. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application (2027-2032) & (US$ Million) Table 192. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026) & (K Units) Table 193. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2027-2032) & (K Units) Table 194. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Price by Application (2021-2026) & (US$/Unit) Table 195. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Price by Application (2027-2032) & (US$/Unit) Table 196. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 197. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 198. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 199. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 200. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021-2026) & (K Units) Table 201. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2027-2032) & (K Units) Table 202. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Price by Country (2021-2026) & (US$/Unit) Table 203. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Price by Country (2027-2032) & (US$/Unit) Table 204. Germany Intravenous Immunoglobulin(IVIg) Therapy Revenue (2021-2032) & (US$ Million) Table 205. France Intravenous Immunoglobulin(IVIg) Therapy Revenue (2021-2032) & (US$ Million) Table 206. U.K. Intravenous Immunoglobulin(IVIg) Therapy Revenue (2021-2032) & (US$ Million) Table 207. Italy Intravenous Immunoglobulin(IVIg) Therapy Revenue (2021-2032) & (US$ Million) Table 208. Netherlands Intravenous Immunoglobulin(IVIg) Therapy Revenue (2021-2032) & (US$ Million) Table 209. China Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type (2021-2026) & (US$ Million) Table 210. China Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type (2027-2032) & (US$ Million) Table 211. China Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026) & (K Units) Table 212. China Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2027-2032) & (K Units) Table 213. China Intravenous Immunoglobulin(IVIg) Therapy Sales Price by Type (2021-2026) & (US$/Unit) Table 214. China Intravenous Immunoglobulin(IVIg) Therapy Sales Price by Type (2027-2032) & (US$/Unit) Table 215. China Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application (2021-2026) & (US$ Million) Table 216. China Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application (2027-2032) & (US$ Million) Table 217. China Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026) & (K Units) Table 218. China Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2027-2032) & (K Units) Table 219. China Intravenous Immunoglobulin(IVIg) Therapy Sales Price by Application (2021-2026) & (US$/Unit) Table 220. China Intravenous Immunoglobulin(IVIg) Therapy Sales Price by Application (2027-2032) & (US$/Unit) Table 221. Asia Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type (2021-2026) & (US$ Million) Table 222. Asia Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type (2027-2032) & (US$ Million) Table 223. Asia Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026) & (K Units) Table 224. Asia Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2027-2032) & (K Units) Table 225. Asia Intravenous Immunoglobulin(IVIg) Therapy Sales Price by Type (2021-2026) & (US$/Unit) Table 226. Asia Intravenous Immunoglobulin(IVIg) Therapy Sales Price by Type (2027-2032) & (US$/Unit) Table 227. Asia Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application (2021-2026) & (US$ Million) Table 228. Asia Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application (2027-2032) & (US$ Million) Table 229. Asia Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026) & (K Units) Table 230. Asia Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2027-2032) & (K Units) Table 231. Asia Intravenous Immunoglobulin(IVIg) Therapy Sales Price by Application (2021-2026) & (US$/Unit) Table 232. Asia Intravenous Immunoglobulin(IVIg) Therapy Sales Price by Application (2027-2032) & (US$/Unit) Table 233. Asia Intravenous Immunoglobulin(IVIg) Therapy Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 234. Asia Intravenous Immunoglobulin(IVIg) Therapy Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 235. Asia Intravenous Immunoglobulin(IVIg) Therapy Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 236. Asia Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 237. Asia Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021-2026) & (K Units) Table 238. Asia Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2027-2032) & (K Units) Table 239. Asia Intravenous Immunoglobulin(IVIg) Therapy Sales Price by Country (2021-2026) & (US$/Unit) Table 240. Asia Intravenous Immunoglobulin(IVIg) Therapy Sales Price by Country (2027-2032) & (US$/Unit) Table 241. Japan Intravenous Immunoglobulin(IVIg) Therapy Revenue (2021-2032) & (US$ Million) Table 242. South Korea Intravenous Immunoglobulin(IVIg) Therapy Revenue (2021-2032) & (US$ Million) Table 243. India Intravenous Immunoglobulin(IVIg) Therapy Revenue (2021-2032) & (US$ Million) Table 244. Australia Intravenous Immunoglobulin(IVIg) Therapy Revenue (2021-2032) & (US$ Million) Table 245. China Taiwan Intravenous Immunoglobulin(IVIg) Therapy Revenue (2021-2032) & (US$ Million) Table 246. Southeast Asia Intravenous Immunoglobulin(IVIg) Therapy Revenue (2021-2032) & (US$ Million) Table 247. SAMEA Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type (2021-2026) & (US$ Million) Table 248. SAMEA Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type (2027-2032) & (US$ Million) Table 249. SAMEA Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026) & (K Units) Table 250. SAMEA Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2027-2032) & (K Units) Table 251. SAMEA Intravenous Immunoglobulin(IVIg) Therapy Sales Price by Type (2021-2026) & (US$/Unit) Table 252. SAMEA Intravenous Immunoglobulin(IVIg) Therapy Sales Price by Type (2027-2032) & (US$/Unit) Table 253. SAMEA Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application (2021-2026) & (US$ Million) Table 254. SAMEA Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application (2027-2032) & (US$ Million) Table 255. SAMEA Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026) & (K Units) Table 256. SAMEA Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2027-2032) & (K Units) Table 257. SAMEA Intravenous Immunoglobulin(IVIg) Therapy Sales Price by Application (2021-2026) & (US$/Unit) Table 258. SAMEA Intravenous Immunoglobulin(IVIg) Therapy Sales Price by Application (2027-2032) & (US$/Unit) Table 259. SAMEA Intravenous Immunoglobulin(IVIg) Therapy Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 260. SAMEA Intravenous Immunoglobulin(IVIg) Therapy Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 261. SAMEA Intravenous Immunoglobulin(IVIg) Therapy Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 262. SAMEA Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 263. SAMEA Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021-2026) & (K Units) Table 264. SAMEA Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2027-2032) & (K Units) Table 265. SAMEA Intravenous Immunoglobulin(IVIg) Therapy Sales Price by Country (2021-2026) & (US$/Unit) Table 266. SAMEA Intravenous Immunoglobulin(IVIg) Therapy Sales Price by Country (2027-2032) & (US$/Unit) Table 267. Brazil Intravenous Immunoglobulin(IVIg) Therapy Revenue (2021-2032) & (US$ Million) Table 268. Argentina Intravenous Immunoglobulin(IVIg) Therapy Revenue (2021-2032) & (US$ Million) Table 269. Chile Intravenous Immunoglobulin(IVIg) Therapy Revenue (2021-2032) & (US$ Million) Table 270. Colombia Intravenous Immunoglobulin(IVIg) Therapy Revenue (2021-2032) & (US$ Million) Table 271. Peru Intravenous Immunoglobulin(IVIg) Therapy Revenue (2021-2032) & (US$ Million) Table 272. Saudi Arabia Intravenous Immunoglobulin(IVIg) Therapy Revenue (2021-2032) & (US$ Million) Table 273. Israel Intravenous Immunoglobulin(IVIg) Therapy Revenue (2021-2032) & (US$ Million) Table 274. UAE Intravenous Immunoglobulin(IVIg) Therapy Revenue (2021-2032) & (US$ Million) Table 275. Turkey Intravenous Immunoglobulin(IVIg) Therapy Revenue (2021-2032) & (US$ Million) Table 276. Iran Intravenous Immunoglobulin(IVIg) Therapy Revenue (2021-2032) & (US$ Million) Table 277. Egypt Intravenous Immunoglobulin(IVIg) Therapy Revenue (2021-2032) & (US$ Million) Table 278. Key Raw Materials Table 279. Raw Materials Key Suppliers Table 280. Intravenous Immunoglobulin(IVIg) Therapy Distributors List Table 281. Intravenous Immunoglobulin(IVIg) Therapy Customers List Table 282. Research Programs/Design for This Report Table 283. Authors List of This Report Table 284. Secondary Sources Table 285. Primary Sources List of Figures Figure 1. Intravenous Immunoglobulin(IVIg) Therapy Image Figure 2. Global Intravenous Immunoglobulin(IVIg) Therapy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intravenous Immunoglobulin(IVIg) Therapy Market Size Share 2021 VS 2025 VS 2032 Figure 4. 5g/100ml Image Figure 5. 2.5g/50ml Image Figure 6. 1g/20ml Image Figure 7. 10g/200ml Image Figure 8. 1.25g/25ml Image Figure 9. Others Image Figure 10. Global Intravenous Immunoglobulin(IVIg) Therapy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Intravenous Immunoglobulin(IVIg) Therapy Market Size Share 2021 VS 2025 VS 2032 Figure 12. Autoimmune Disease Image Figure 13. Immunodeficiency Image Figure 14. Acute Infection Image Figure 15. Others Image Figure 16. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue (2021-2032) & (US$ Million) Figure 18. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Region (2021-2032) Figure 21. Global Intravenous Immunoglobulin(IVIg) Therapy Sales (2021-2032) & (K Units) Figure 22. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 23. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Intravenous Immunoglobulin(IVIg) Therapy Sales YoY (2021-2032) & (K Units) Figure 25. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales YoY (2021-2032) & (K Units) Figure 26. China Intravenous Immunoglobulin(IVIg) Therapy Sales YoY (2021-2032) & (K Units) Figure 27. Asia (Excluding China) Intravenous Immunoglobulin(IVIg) Therapy Sales YoY (2021-2032) & (K Units) Figure 28. South America, Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales YoY (2021-2032) & (K Units) Figure 29. Global Intravenous Immunoglobulin(IVIg) Therapy Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Intravenous Immunoglobulin(IVIg) Therapy Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Type (2021-2032) Figure 35. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2021-2032) Figure 38. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Application (2021-2032) Figure 41. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 42. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2021-2032) Figure 44. North America Intravenous Immunoglobulin(IVIg) Therapy Revenue Share by Type (2021-2032) Figure 45. North America Intravenous Immunoglobulin(IVIg) Therapy Sales Share by Type (2021-2032) Figure 46. North America Intravenous Immunoglobulin(IVIg) Therapy Revenue Share by Application (2021-2032) Figure 47. North America Intravenous Immunoglobulin(IVIg) Therapy Sales Share by Application (2021-2032) Figure 48. North America Intravenous Immunoglobulin(IVIg) Therapy Revenue Share by Country (2021-2032) Figure 49. North America Intravenous Immunoglobulin(IVIg) Therapy Sales Share by Country (2021-2032) Figure 50. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue Share by Type (2021-2032) Figure 51. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Share by Type (2021-2032) Figure 52. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue Share by Application (2021-2032) Figure 53. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Share by Application (2021-2032) Figure 54. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue Share by Country (2021-2032) Figure 55. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Share by Country (2021-2032) Figure 56. China Intravenous Immunoglobulin(IVIg) Therapy Revenue Share by Type (2021-2032) Figure 57. China Intravenous Immunoglobulin(IVIg) Therapy Sales Share by Type (2021-2032) Figure 58. China Intravenous Immunoglobulin(IVIg) Therapy Revenue Share by Application (2021-2032) Figure 59. China Intravenous Immunoglobulin(IVIg) Therapy Sales Share by Application (2021-2032) Figure 60. Asia Intravenous Immunoglobulin(IVIg) Therapy Revenue Share by Type (2021-2032) Figure 61. Asia Intravenous Immunoglobulin(IVIg) Therapy Sales Share by Type (2021-2032) Figu

Scope & coverage.

Types
  • 5g/100ml
  • 2.5g/50ml
  • 1g/20ml
  • 10g/200ml
  • 1.25g/25ml
  • Others
Applications
  • Autoimmune Disease
  • Immunodeficiency
  • Acute Infection
  • Others
Companies covered
  • TEIJIN LIMITED
  • Baxter
  • Biotest
  • Boya-Bio
  • CNBG
  • CSL Plasma
  • Grifols
  • Kamada
  • Kedrion
  • LFB Group
  • Nanyue Biopharming
  • Octapharma
  • Sinopharm
  • Beijing Tiantan Biological Products
  • Guangdong Shuagnlin Bio-pharmacy
  • Hualan Bio
  • Shanghai RAAS
  • Weiguang Biological
  • Taibang Biologic Group
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Intravenous Immunoglobulin(IVIg) Therapy Market by Type
  3. 1.2.1 Global Intravenous Immunoglobulin(IVIg) Therapy Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 5g/100ml
  5. 1.2.3 2.5g/50ml
  6. 1.2.4 1g/20ml
  7. 1.2.5 10g/200ml
  8. 1.2.6 1.25g/25ml
  9. 1.2.7 Others
  10. 1.3 Intravenous Immunoglobulin(IVIg) Therapy Market by Application
  11. 1.3.1 Global Intravenous Immunoglobulin(IVIg) Therapy Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Autoimmune Disease
  13. 1.3.3 Immunodeficiency
  14. 1.3.4 Acute Infection
  15. 1.3.5 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Intravenous Immunoglobulin(IVIg) Therapy Market Dynamics
  1. 2.1 Intravenous Immunoglobulin(IVIg) Therapy Industry Trends
  2. 2.2 Intravenous Immunoglobulin(IVIg) Therapy Industry Drivers
  3. 2.3 Intravenous Immunoglobulin(IVIg) Therapy Industry Opportunities and Challenges
  4. 2.4 Intravenous Immunoglobulin(IVIg) Therapy Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region
  3. 3.2.1 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region (2021-2026)
  5. 3.2.3 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region (2027-2032)
  6. 3.2.4 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Region
  9. 3.4.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Region (2021-2026)
  11. 3.4.3 Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Region (2027-2032)
  12. 3.4.4 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Manufacturers
  2. 4.1.1 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Intravenous Immunoglobulin(IVIg) Therapy Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Manufacturers
  6. 4.2.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Intravenous Immunoglobulin(IVIg) Therapy Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Intravenous Immunoglobulin(IVIg) Therapy Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Intravenous Immunoglobulin(IVIg) Therapy Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Intravenous Immunoglobulin(IVIg) Therapy Manufacturers, Product Type & Application
  13. 4.7 Global Intravenous Immunoglobulin(IVIg) Therapy Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Intravenous Immunoglobulin(IVIg) Therapy Market CR5 and HHI
  16. 4.8.2 2025 Intravenous Immunoglobulin(IVIg) Therapy Tier 1, Tier 2, and Tier 3
5 Intravenous Immunoglobulin(IVIg) Therapy Market by Type
  1. 5.1 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type
  2. 5.1.1 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Type
  6. 5.2.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2021-2032)
  9. 5.3 Global Intravenous Immunoglobulin(IVIg) Therapy Price by Type
6 Intravenous Immunoglobulin(IVIg) Therapy Market by Application
  1. 6.1 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application
  2. 6.1.1 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Application
  6. 6.2.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2021-2032)
  9. 6.3 Global Intravenous Immunoglobulin(IVIg) Therapy Price by Application
7 Company Profiles
  1. 7.1 TEIJIN LIMITED
  2. 7.1.1 TEIJIN LIMITED Company Information
  3. 7.1.2 TEIJIN LIMITED Business Overview
  4. 7.1.3 TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  6. 7.1.5 TEIJIN LIMITED Recent Developments
  7. 7.2 Baxter
  8. 7.2.1 Baxter Company Information
  9. 7.2.2 Baxter Business Overview
  10. 7.2.3 Baxter Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Baxter Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  12. 7.2.5 Baxter Recent Developments
  13. 7.3 Biotest
  14. 7.3.1 Biotest Company Information
  15. 7.3.2 Biotest Business Overview
  16. 7.3.3 Biotest Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Biotest Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  18. 7.3.5 Biotest Recent Developments
  19. 7.4 Boya-Bio
  20. 7.4.1 Boya-Bio Company Information
  21. 7.4.2 Boya-Bio Business Overview
  22. 7.4.3 Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  24. 7.4.5 Boya-Bio Recent Developments
  25. 7.5 CNBG
  26. 7.5.1 CNBG Company Information
  27. 7.5.2 CNBG Business Overview
  28. 7.5.3 CNBG Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 CNBG Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  30. 7.5.5 CNBG Recent Developments
  31. 7.6 CSL Plasma
  32. 7.6.1 CSL Plasma Company Information
  33. 7.6.2 CSL Plasma Business Overview
  34. 7.6.3 CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  36. 7.6.5 CSL Plasma Recent Developments
  37. 7.7 Grifols
  38. 7.7.1 Grifols Company Information
  39. 7.7.2 Grifols Business Overview
  40. 7.7.3 Grifols Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Grifols Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  42. 7.7.5 Grifols Recent Developments
  43. 7.8 Kamada
  44. 7.8.1 Kamada Company Information
  45. 7.8.2 Kamada Business Overview
  46. 7.8.3 Kamada Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Kamada Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  48. 7.8.5 Kamada Recent Developments
  49. 7.9 Kedrion
  50. 7.9.1 Kedrion Company Information
  51. 7.9.2 Kedrion Business Overview
  52. 7.9.3 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  54. 7.9.5 Kedrion Recent Developments
  55. 7.10 LFB Group
  56. 7.10.1 LFB Group Company Information
  57. 7.10.2 LFB Group Business Overview
  58. 7.10.3 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  60. 7.10.5 LFB Group Recent Developments
  61. 7.11 Nanyue Biopharming
  62. 7.11.1 Nanyue Biopharming Company Information
  63. 7.11.2 Nanyue Biopharming Business Overview
  64. 7.11.3 Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  66. 7.11.5 Nanyue Biopharming Recent Developments
  67. 7.12 Octapharma
  68. 7.12.1 Octapharma Company Information
  69. 7.12.2 Octapharma Business Overview
  70. 7.12.3 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  72. 7.12.5 Octapharma Recent Developments
  73. 7.13 Sinopharm
  74. 7.13.1 Sinopharm Company Information
  75. 7.13.2 Sinopharm Business Overview
  76. 7.13.3 Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  78. 7.13.5 Sinopharm Recent Developments
  79. 7.14 Beijing Tiantan Biological Products
  80. 7.14.1 Beijing Tiantan Biological Products Company Information
  81. 7.14.2 Beijing Tiantan Biological Products Business Overview
  82. 7.14.3 Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  84. 7.14.5 Beijing Tiantan Biological Products Recent Developments
  85. 7.15 Guangdong Shuagnlin Bio-pharmacy
  86. 7.15.1 Guangdong Shuagnlin Bio-pharmacy Company Information
  87. 7.15.2 Guangdong Shuagnlin Bio-pharmacy Business Overview
  88. 7.15.3 Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  90. 7.15.5 Guangdong Shuagnlin Bio-pharmacy Recent Developments
  91. 7.16 Hualan Bio
  92. 7.16.1 Hualan Bio Company Information
  93. 7.16.2 Hualan Bio Business Overview
  94. 7.16.3 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  96. 7.16.5 Hualan Bio Recent Developments
  97. 7.17 Shanghai RAAS
  98. 7.17.1 Shanghai RAAS Company Information
  99. 7.17.2 Shanghai RAAS Business Overview
  100. 7.17.3 Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  102. 7.17.5 Shanghai RAAS Recent Developments
  103. 7.18 Weiguang Biological
  104. 7.18.1 Weiguang Biological Company Information
  105. 7.18.2 Weiguang Biological Business Overview
  106. 7.18.3 Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  108. 7.18.5 Weiguang Biological Recent Developments
  109. 7.19 Taibang Biologic Group
  110. 7.19.1 Taibang Biologic Group Company Information
  111. 7.19.2 Taibang Biologic Group Business Overview
  112. 7.19.3 Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  114. 7.19.5 Taibang Biologic Group Recent Developments
  115. 7.20 Takeda
  116. 7.20.1 Takeda Company Information
  117. 7.20.2 Takeda Business Overview
  118. 7.20.3 Takeda Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Takeda Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  120. 7.20.5 Takeda Recent Developments
8 North America
  1. 8.1 North America Intravenous Immunoglobulin(IVIg) Therapy Market Size by Type
  2. 8.1.1 North America Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type (2021-2032)
  3. 8.1.2 North America Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2032)
  4. 8.1.3 North America Intravenous Immunoglobulin(IVIg) Therapy Price by Type (2021-2032)
  5. 8.2 North America Intravenous Immunoglobulin(IVIg) Therapy Market Size by Application
  6. 8.2.1 North America Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application (2021-2032)
  7. 8.2.2 North America Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2032)
  8. 8.2.3 North America Intravenous Immunoglobulin(IVIg) Therapy Price by Application (2021-2032)
  9. 8.3 North America Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country
  10. 8.3.1 North America Intravenous Immunoglobulin(IVIg) Therapy Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Intravenous Immunoglobulin(IVIg) Therapy Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Intravenous Immunoglobulin(IVIg) Therapy Market Size by Type
  2. 9.1.1 Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type (2021-2032)
  3. 9.1.2 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2032)
  4. 9.1.3 Europe Intravenous Immunoglobulin(IVIg) Therapy Price by Type (2021-2032)
  5. 9.2 Europe Intravenous Immunoglobulin(IVIg) Therapy Market Size by Application
  6. 9.2.1 Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application (2021-2032)
  7. 9.2.2 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2032)
  8. 9.2.3 Europe Intravenous Immunoglobulin(IVIg) Therapy Price by Application (2021-2032)
  9. 9.3 Europe Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country
  10. 9.3.1 Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Intravenous Immunoglobulin(IVIg) Therapy Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Intravenous Immunoglobulin(IVIg) Therapy Market Size by Type
  2. 10.1.1 China Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type (2021-2032)
  3. 10.1.2 China Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2032)
  4. 10.1.3 China Intravenous Immunoglobulin(IVIg) Therapy Price by Type (2021-2032)
  5. 10.2 China Intravenous Immunoglobulin(IVIg) Therapy Market Size by Application
  6. 10.2.1 China Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application (2021-2032)
  7. 10.2.2 China Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2032)
  8. 10.2.3 China Intravenous Immunoglobulin(IVIg) Therapy Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Intravenous Immunoglobulin(IVIg) Therapy Market Size by Type
  2. 11.1.1 Asia Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type (2021-2032)
  3. 11.1.2 Asia Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2032)
  4. 11.1.3 Asia Intravenous Immunoglobulin(IVIg) Therapy Price by Type (2021-2032)
  5. 11.2 Asia Intravenous Immunoglobulin(IVIg) Therapy Market Size by Application
  6. 11.2.1 Asia Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application (2021-2032)
  7. 11.2.2 Asia Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2032)
  8. 11.2.3 Asia Intravenous Immunoglobulin(IVIg) Therapy Price by Application (2021-2032)
  9. 11.3 Asia Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country
  10. 11.3.1 Asia Intravenous Immunoglobulin(IVIg) Therapy Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Intravenous Immunoglobulin(IVIg) Therapy Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Intravenous Immunoglobulin(IVIg) Therapy Market Size by Type
  2. 12.1.1 SAMEA Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Intravenous Immunoglobulin(IVIg) Therapy Price by Type (2021-2032)
  5. 12.2 SAMEA Intravenous Immunoglobulin(IVIg) Therapy Market Size by Application
  6. 12.2.1 SAMEA Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Intravenous Immunoglobulin(IVIg) Therapy Price by Application (2021-2032)
  9. 12.3 SAMEA Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country
  10. 12.3.1 SAMEA Intravenous Immunoglobulin(IVIg) Therapy Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Intravenous Immunoglobulin(IVIg) Therapy Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Intravenous Immunoglobulin(IVIg) Therapy Value Chain Analysis
  2. 13.1.1 Intravenous Immunoglobulin(IVIg) Therapy Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Intravenous Immunoglobulin(IVIg) Therapy Production Mode & Process
  6. 13.2 Intravenous Immunoglobulin(IVIg) Therapy Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Intravenous Immunoglobulin(IVIg) Therapy Distributors
  9. 13.2.3 Intravenous Immunoglobulin(IVIg) Therapy Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst